Your browser doesn't support javascript.
loading
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
Rambau, Peter F; Vierkant, Robert A; Intermaggio, Maria P; Kelemen, Linda E; Goodman, Marc T; Herpel, Esther; Pharoah, Paul D; Kommoss, Stefan; Jimenez-Linan, Mercedes; Karlan, Beth Y; Gentry-Maharaj, Aleksandra; Menon, Usha; Polo, Susanna Hernando; Candido Dos Reis, Francisco J; Doherty, Jennifer Anne; Gayther, Simon A; Sharma, Raghwa; Larson, Melissa C; Harnett, Paul R; Hatfield, Emma; de Andrade, Jurandyr M; Nelson, Gregg S; Steed, Helen; Schildkraut, Joellen M; Carney, Micheal E; Høgdall, Estrid; Whittemore, Alice S; Widschwendter, Martin; Kennedy, Catherine J; Wang, Frances; Wang, Qin; Wang, Chen; Armasu, Sebastian M; Daley, Frances; Coulson, Penny; Jones, Micheal E; Anglesio, Micheal S; Chow, Christine; de Fazio, Anna; García-Closas, Montserrat; Brucker, Sara Y; Cybulski, Cezary; Harris, Holly R; Hartkopf, Andreas D; Huzarski, Tomasz; Jensen, Allan; Lubinski, Jan; Oszurek, Oleg; Benitez, Javier; Mina, Fady.
Affiliation
  • Rambau PF; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
  • Vierkant RA; Pathology Department, Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania.
  • Intermaggio MP; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Kelemen LE; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
  • Goodman MT; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Herpel E; Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Pharoah PD; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Kommoss S; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Jimenez-Linan M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Karlan BY; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Gentry-Maharaj A; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
  • Menon U; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Polo SH; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Candido Dos Reis FJ; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Doherty JA; Medical Oncology Service, Hospital Universitario Funcación Alcorcón, Alcorcón, Spain.
  • Gayther SA; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Sharma R; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Larson MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Harnett PR; Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hatfield E; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • de Andrade JM; Pathology West ICPMR Westmead, Westmead Hospital, The University of Sydney, Sydney, NSW, Australia.
  • Nelson GS; University of Western Sydney at Westmead Hospital, Westmead, NSW, Australia.
  • Steed H; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Schildkraut JM; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
  • Carney ME; The Crown Princess Mary Cancer Centre Westmead, Sydney-West Cancer Network, Westmead Hospital, Sydney, NSW, Australia.
  • Høgdall E; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
  • Whittemore AS; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Widschwendter M; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Kennedy CJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Royal Alexandra Hospital, Edmonton, AB, Canada.
  • Wang F; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
  • Wang Q; John A. Burns School of Medicine, Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI, USA.
  • Wang C; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Armasu SM; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Daley F; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Coulson P; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
  • Jones ME; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Anglesio MS; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
  • Chow C; Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia.
  • de Fazio A; Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.
  • García-Closas M; Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA.
  • Brucker SY; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Cybulski C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Harris HR; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Hartkopf AD; Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
  • Huzarski T; Division of Bioscience, Brunel University, London, UK.
  • Jensen A; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Lubinski J; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Oszurek O; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Benitez J; Genetic Pathology Evaluation Centre, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Mina F; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
J Pathol Clin Res ; 4(4): 250-261, 2018 10.
Article in En | MEDLINE | ID: mdl-30062862

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Ovary / Cystadenocarcinoma, Serous / Adenocarcinoma, Mucinous / Cyclin-Dependent Kinase Inhibitor p16 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Pathol Clin Res Year: 2018 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Ovary / Cystadenocarcinoma, Serous / Adenocarcinoma, Mucinous / Cyclin-Dependent Kinase Inhibitor p16 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Pathol Clin Res Year: 2018 Type: Article Affiliation country: Canada